Cowen and Company’s Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 PCPC.WS Stock Holding History

Cowen and Company’s Portfolio PCPC.WS Stock Details PCPC.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-24,754	Closed	-$18K	–	823
2022 Q1	$18K	Buy	+24,754	New	+$23.9K	﹤0.01%	449

Other funds holding PCPC.WS

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

SRCM

Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

AMH

Apollo Management Holdings New York $8.94B AUM 120.19% 1-Year Est. Return

Cowen and Company's PCPC.WS Position: Q2 2022 in Review

Cowen and Company sold out of Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 (PCPC.WS) in Q2 2022, closing a stake of 24,754 shares — an estimated $18K sold.

Cowen and Company first reported a position in PCPC.WS in Q1 2022 and held it in 1 quarter. The position peaked at $18K in Q1 2022. 29 funds tracked by Wall St. Rank hold PCPC.WS as of Q2 2022.

Cowen and Company reported no remaining Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 position as of Q2 2022 after selling out during the quarter.
Cowen and Company sold 24,754 Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 shares in Q2 2022, an estimated $18K.
Cowen and Company first reported a position in Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 in Q1 2022 and held it in 1 quarter.
Cowen and Company's Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 position peaked at $18K in Q1 2022.
29 funds tracked by Wall St. Rank held Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75 as of Q2 2022.

Based on Cowen and Company's 13F filing for Q2 2022, filed 5 Aug 2022.